课题基金 / 基金详情

项目摘要

项目成果

Brad Amendt的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):我们的长期目标是了解HIV-1如何调节其基因产物的水平,以优化病毒复制。优化HIV-1基因表达的方法之一是通过选择性RNA剪接,这是产生适当水平的不同HIV-1 mRNAs所必需的过程。干扰HIV-1选择性剪接可能是一种新的抗病毒治疗方法。基本的HIV-1剪接模式在所有的HIV-1毒株中都是保守的,这表明它对病毒复制的重要性。不同剪接位点的使用效率由剪接位点本身和基因组中称为外显子剪接沉默因子(ESS)和外显子剪接增强子(ESE)的顺式元件决定。建议的研究是由我们最近的结果推动的,这些结果表明了一些元素对病毒复制的关键重要性。首先,我们将在剪接位点和剪接元件中创建额外的突变,并研究它们在确定病毒Vif蛋白表达水平和病毒复制中的作用。Vif蛋白是一种用来灭活抗病毒细胞蛋白APOBEC3G的蛋白质。其次,我们将分离新生的HIV-1信使核糖核酸,以确定病毒信使核糖核酸在生命周期的哪个时间点发生剪接--无论是在RNA转录完成期间还是之后。最后,我们将研究异常O组病毒与主要M组毒株的剪接调控。O组病毒似乎使用与M组HIV-1毒株不同的顺式元件来调节剪接。对这些因素的识别可能会让我们对HIV-1的进化有新的见解。
英文摘要
DESCRIPTION (provided by applicant): Our long range objective is to understand how HIV-1 regulates the levels of its gene products to optimize virus replication. One of the ways gene expression of HIV-1 is optimized is through alternative RNA splicing, a process which is necessary to produce the appropriate levels of the different HIV-1 mRNAs . Interference with HIV-1 alternative splicing may be a novel approach for antiviral therapy. The basic HIV-1 splicing pattern is conserved in all strains of HIV-1 suggesting its importance for viral replication. The efficiencies with which different splice sites are used are determined by the splice sites themselves and cis elements within the genome called exonic splicing silencers (ESS) and exonic splicing enhancers (ESE). The proposed studies are driven by our recent results indicating the crucial importance of some of the elements for virus replication. First, we will create additional mutations within splice sites and splicing elements and study their role in determining the level of expression of the viral Vif protein, a protein which acts to inactivate the antiviral cellular protein APOBEC3G, and in virus replication. Second, we will isolate nascent HIV-1 mRNA to determine at what point in the lifetime of the viral mRNA that splicing takes place-whether it is during or after RNA transcription is completed. Finally, we will study regulation of splicing of the outlier Group O viruses compared to the major Group M strains. Group O viruses appear to use different cis elements than Group M HIV-1 strains to regulate splicing. Identification of these elements may give us new insights about the evolution of HIV-1.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.
用于剪接 HIV-1 env/nef 和 rev mRNA 的重叠顺式位点。
DOI: 10.1074/jbc.273.51.34551
发表时间: 1998
期刊: The Journal of biological chemistry
影响因子: --
作者: [Swanson,AK, Stoltzfus,CM]
通讯作者: Stoltzfus,CM
DOI: 10.1016/s0065-3527(09)74001-1
发表时间: 2009
期刊: Advances in virus research
影响因子: --
作者: [C. Stoltzfus]
通讯作者: C. Stoltzfus
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
人类免疫缺陷病毒 1 型 tat 外显子 2 和 tat-rev 外显子 3 中存在外显子剪接沉默子:细胞因子介导抑制的证据。
DOI: 10.1128/mcb.15.8.4606
发表时间: 1995
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Amendt,BA, Si,ZH, Stoltzfus,CM]
通讯作者: Stoltzfus,CM
Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.
通过激活隐秘剪接位点修复 Rev-minus 人类免疫缺陷病毒 1 型突变体。
DOI: 10.1128/jvi.75.7.3495-3500.2001
发表时间: 2001
期刊: Journal of virology
影响因子: 5.4
作者: [Verhoef,K, Bilodeau,PS, vanWamel,JL, Kjems,J, Stoltzfus,CM, Berkhout,B]
通讯作者: Berkhout,B
Training in Molecular Virology and Viral Pathogenesis
  • 批准号:
    7101880
  • 项目类别:
  • 资助金额:
    $10.05万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
  • 批准号:
    2653779
  • 项目类别:
  • 资助金额:
    $3.91万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
  • 批准号:
    6372845
  • 项目类别:
  • 资助金额:
    $7.72万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
  • 批准号:
    6169085
  • 项目类别:
  • 资助金额:
    $7.25万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
海外基金